Cargando…
Publisher Correction: A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing
Autores principales: | Habibi, Mahnaz, Taheri, Golnaz, Aghdam, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312203/ https://www.ncbi.nlm.nih.gov/pubmed/34312434 http://dx.doi.org/10.1038/s41598-021-94440-w |
Ejemplares similares
-
A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing
por: Habibi, Mahnaz, et al.
Publicado: (2021) -
Using informative features in machine learning based method for COVID-19 drug repurposing
por: Aghdam, Rosa, et al.
Publicado: (2021) -
Topological network based drug repurposing for coronavirus 2019
por: Habibi, Mahnaz, et al.
Publicado: (2021) -
Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
por: Pirolli, Davide, et al.
Publicado: (2023) -
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Redhead, Martin A., et al.
Publicado: (2021)